Latest Updates

Lobular Breast Cancer

Tari A King, MD, Anita Mamtani, MD
    • Recognition of invasive lobular cancer as a biologically unique entity from invasive ductal cancer
    • Identification of novel mutations more frequently identified in invasive lobular cancers in The Cancer Genome Analysis (TCGA) study
    • Multimodality treatment approaches with an emphasis on tumor biology
    • Consensus guidelines for negative margins at lumpectomy and applicability to lobular cancers
    • Impact and utility of neoadjuvant chemotherapy and neoadjuvant endocrine therapy in lobular cancers

Understanding the Genetics of Pancreatic Adenocarcinoma

Apoorve Nayyar, MBBS, Post-Doctoral Research Associate,, Jen Jen Yeh, MD
    • Whole genome/exome sequencing
    • RNA expression analysis
    • Genome-wide association studies

Small Intestine: Adenocarcinoma

Sudeep Banerjee, MD, Joel M Baumgartner, MD, MAS, Jason K Sicklick, MD
    • Genetic pathways implicated in small bowel adenocarcinoma (APC, TP53, β-catenin, SMAD4, microsatellite instability, K-ras) are similar to colorectal adenocarcinoma but less well understood.
    • Advanced endoscopy or enteroscopy can be used to obtain preoperative diagnosis.
    • Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy may offer improved survival for a subset of patients with peritoneal metastasis.

Small Intestine: Adenocarcinoma

Sudeep Banerjee, MD, Joel M Baumgartner, MD, MAS, Jason K Sicklick, MD
    • Genetic pathways implicated in small bowel adenocarcinoma (APC, TP53, β-catenin, SMAD4, microsatellite instability, K-ras) are similar to colorectal adenocarcinoma but less well understood.
    • Advanced endoscopy or enteroscopy can be used to obtain preoperative diagnosis.
    • Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy may offer improved survival for a subset of patients with peritoneal metastasis.

Small Intestine: Neuroendocrine and Miscellaneous Tumors

Sudeep Banerjee, MD, Joel M Baumgartner, MD, MAS, Jason K Sicklick, MD
    • Functional PET/CT with gallium-68 dotatate provides improved sensitivity and resolution compared with traditional imaging methods.
    • Hepatic transarterial embolizations can improve carcinoid-related symptoms in patients who are not surgical candidates or have unresectable disease.
    • Somatostatin analogues remain the mainstay of systemic therapy for carcinoid, whereas targeted agents and cytotoxic chemotherapy are areas of active investigation.

Management of Recurrent Retroperitoneal Sarcoma

Charles Catton, MD, FRCPC, Rebecca Gladdy, MD, PhD, FRCSC, Abha Gupta, MD, MSc, FRCPC, Armen Parsyan, MD, PhD, DSc, MPH, FRCSC
    • Better understanding of the patterns of failure such that patients at high risk for relapse are identified
    • Improved understanding of the molecular basis of sarcomas impacting our ability to diagnose and predict the biologic behavior and to further inform management algorithms
    • Successful completion of a randomized clinical trial to determine the effects of preoperative radiation therapy on local recurrence in primary resectable retroperitoneal sarcoma 

Small Intestine: Neuroendocrine and Miscellaneous Tumors

Sudeep Banerjee, MD, Joel M Baumgartner, MD, MAS, Jason K Sicklick, MD
    • Functional PET/CT with gallium-68 dotatate provides improved sensitivity and resolution compared with traditional imaging methods.
    • Hepatic transarterial embolizations can improve carcinoid-related symptoms in patients who are not surgical candidates or have unresectable disease.
    • Somatostatin analogues remain the mainstay of systemic therapy for carcinoid, whereas targeted agents and cytotoxic chemotherapy are areas of active investigation.

Management of Recurrent Retroperitoneal Sarcoma

Charles Catton, MD, FRCPC, Rebecca Gladdy, MD, PhD, FRCSC, Abha Gupta, MD, MSc, FRCPC, Armen Parsyan, MD, PhD, DSc, MPH, FRCSC
    • Better understanding of the patterns of failure such that patients at high risk for relapse are identified
    • Improved understanding of the molecular basis of sarcomas impacting our ability to diagnose and predict the biologic behavior and to further inform management algorithms
    • Successful completion of a randomized clinical trial to determine the effects of preoperative radiation therapy on local recurrence in primary resectable retroperitoneal sarcoma 
« Previous | Next »
Updates per yearSpecialty updatesNumber of sections